No Data
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
U.S. Healthcare Spending Climbs 7.5% in 2023
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
25 U.S. 'Highest Conviction' Stocks – UBS
The Medical assistance program may come under pressure as Morgan Stanley downgrades Elevance Health (ELV.US).
Elevance Health (ELV.US) faces pressure in its Medical assistance Business, and Morgan Stanley downgraded the stock rating from "Shareholding" to "Hold" on Tuesday.
Elevance Downgraded at Morgan Stanley on Medicaid Headwinds